George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.70
Bid: 18.40
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.60 (3.261%)
Open: 18.70
High: 18.70
Low: 18.70
Prev. Close: 18.70
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Europe-wide Patent Granted for G+ in Golf Balls

29 Mar 2021 07:00

RNS Number : 7227T
Directa Plus PLC
29 March 2021
 

This is a Reach announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

29 March 2021

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Europe-wide Patent Granted for G+ in Golf Balls

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the Company has been granted an EU-wide patent covering the use of its G+® graphene in golf ball applications. The reference date for the patent is 23 December 2016.

 

The patent covers a family of formulations and compounds containing G+® graphene nanoplatelets for golf ball applications. Using these compounds at different loadings provides the basis for developing a new generation of high-performance golf balls aimed at both the professional and recreational markets. For professionals, G+® can be used to enhance the hard-core of golf balls to maximise shot distance, without losing lateral control. For amateurs, a different formulation of G+® can be used to increase distance while at the same time maximising control.

 

Following the grant of patent, Directa Plus will commence a selection process for a partner to commercialise the technology.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "The award of a Europe-wide patent for our G+® technology in golf balls is the first step towards addressing a very large global market. Our technology can deliver material benefits in terms of both distance and control to professional and recreational golfers. We look forward to working with our chosen partner to designing and launching a new generation of high-performance golf balls."

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald / Pete Lynch

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Rick Thompson / Phil Davies

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson / Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+® products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASELFAAEFSEID
Date   Source Headline
15th Jan 20217:00 amRNSExercise of Options and Director / PDMR Dealing
11th Jan 20219:06 amRNSSecond Price Monitoring Extn
11th Jan 20219:00 amRNSPrice Monitoring Extension
11th Jan 20217:00 amRNSTrading Update
3rd Dec 20207:00 amRNSTrading Update
23rd Nov 20202:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20202:01 pmRNSPrice Monitoring Extension
23rd Nov 202011:05 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
23rd Nov 20207:00 amRNSUpdate on Partner NexTech Batteries
17th Nov 20207:00 amRNSGrant of Options
26th Oct 20207:00 amRNSGraphene for Use in Lithium Sulphur Batteries
14th Oct 20207:00 amRNSSetcar Update
24th Sep 20207:00 amRNSHalf-year Report
9th Sep 20207:00 amRNSPublication of Scientific Paper
13th Aug 20207:00 amRNSCo-Mask Anti-Viral (COVID-19) Properties Confirmed
10th Aug 20207:00 amRNSAgreement with Poltrona Frau
4th Aug 20207:00 amRNSNew San Giorgio Bridge Opens with Gipave Asphalt
30th Jul 20207:00 amRNSItalian Patent Grant for Shoe Outsoles
29th Jul 20209:00 amRNSPrice Monitoring Extension
29th Jul 20207:00 amRNSAgreement with Italdesign
28th Jul 20207:00 amRNSAppointment of Nominated Adviser and Joint Broker
27th Jul 20204:46 pmRNSTotal Voting Rights
13th Jul 20207:00 amRNSAward of Waste Management Contract
1st Jul 202011:57 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSDirector/PDMR Shareholding
26th Jun 202012:56 pmRNSResult of AGM
25th Jun 20207:00 amRNSGipave graphene asphalt trial in Kent
23rd Jun 202010:21 amRNSDirector/PDMR Shareholding
22nd Jun 20207:00 amRNSGrant of Chinese Patent
19th Jun 20207:00 amRNSLaunch of Co-Mask
1st Jun 20205:30 pmRNSPosting of Annual Report & Notice of AGM
26th May 20207:00 amRNSGrant of Key Textile Patent
21st May 20207:00 amRNSFinal Results
18th May 20207:00 amRNSTechnology Innovation Award from Frost & Sullivan
27th Apr 20207:00 amRNSEuropean Patent Grant
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
14th Apr 20207:00 amRNSAgreement with Iterchimica
30th Mar 20202:05 pmRNSSecond Price Monitoring Extn
30th Mar 20202:00 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSCovid-19 Update
13th Mar 20207:00 amRNSTrading Update
12th Feb 20207:00 amRNSEco certification of graphene printing technology
3rd Feb 20207:00 amRNSAward of Environmental services contract
27th Jan 20207:00 amRNSEU Grant for Eco-friendly G+ Printing Technology
20th Jan 20207:00 amRNSR&D Agreement with Comerio Ercole
9th Dec 20197:00 amRNSAward of Environmental Services Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.